To access all features of this site, you must enable Javascript. Here are the instructions for enabling Javascript in your web browser.
To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
All the news of the Institute of life sciences Frédéric Joliot
A collaboration between teams from SIMOPRO and Sanofi sheds new light on the origin of the immune responses developed by patients with scleroderma when treated by injection of relaxin, a therapeutic protein. The study was published in The Journal of Immunology.
As part of a collaboration with MIRCen (Jacob Institute), researchers of SCBM have developed functional micellar vectors that can effectively target tumors and whose therapeutic activity is intrinsically carried by the constitutive unit of the micelle. This combination leads to better drug load and avoids premature drug release.
The magnet of the future MRI at 11.7 teslas of the Iseult project at NeuroSpin (CEA Paris-Saclay) reached a magnetic field of 9.51 teslas during tests carried out on Wednesday 22 May. This new level is a record since the magnet has become on this occasion the most powerful MRI magnet in the world for imaging in humans with a stored energy of 221 MJ. This successful outcome is the result of the work of the Iseult project’s team from the CEA.
The Fresnel Institute, in collaboration with the University of St Petersburg and a team from NeuroSpin, has developed a new ceramic resonator (probe) suitable for 17T magnetic resonance microscopy, i.e. for spatial resolutions below 100 μm3. This probe allows the production of MRI images with a signal-to-noise ratio 2 times greater than those obtained with reference probes, in copper.
Two teams from JOLIOT (SPI / SCBM), in collaboration with the University of Cincinnati, confirm the interest of a drug candidate to treat the congenital creatine deficiency syndrome, a rare neurological childhood disease, responsible for developmental delays and intellectual disability. The results obtained in an animal model of the disease show that it is possible to administer, nasally, dodecyl creatine ester-loaded microspheres, thus improving the cognitive functions of treated animals.
The French National Infrastructure of Integrated Structural Biology (FRISBI) is now integratinf Genopole's structural biology platform into its Paris-Sud node.
A team of NeuroSpin (GIN Bordeaux), within a multidisciplinary consortium, led an exploratory study of whole genome sequencing to search for rare genetic mutations that may be implicated in the atypical inverted right-hemispheric dominance for language (DLAtyp), present in less than 1% of the adult population. A higher rate of mutations affecting the actin cytoskeleton was revealed in DLAtyp individuals identified by functional MRI.
The M-CUBE consortium, funded by the H2020 program, is now listed in the "success stories" of the European Commission website. A further confirmation of the interest of the work of NeuroSpin physicits and their collaborators on metamaterials to "boost" the MRI of the future.
Top page
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.